LYMPHOCYTE SUBSETS IN PLEURAL EFFUSIONS (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


LYMPHOCYTE SUBSETS IN PLEURAL EFFUSIONS (MEETING ABSTRACT)

Chest; 100(2, Suppl):41S 1991. Unique Identifier : AIDSLINE ICDB/92679233
Chiner E; Larramendi CH; Calpe J; Munoz J; Chest and Immunology Sections, Hosp. de la Vila Joiosa-Benidorm,; Spain


Abstract: Differences between pleural fluid and blood lymphocyte subsets have been scarcely studied. We have evaluated a group of 19 patients with pleural effusion (PE) of diverse etiology (10 transudates [Tr] and 9 exudates [Ex]) according to the Light's criteria. Quantitation of lymphocyte subsets was performed by cell flow cytometry in PE and blood (B) samples simultaneously. Results are presented in a table. In all pleural fluids (Tr+Ex), an increase in T4 and T4/T8 ratio was observed compared with B (p less than 0.01). Similar changes existed in Tr but T8 were lower in Pe than in B (p less than 0.05). However, no differences were observed in Ex between PE and B; T4 were slightly higher in PE than in B (p less than 0.01). Between Tr and Ex there only appeared differences for T4 in B (p less than 0.05). The only difference in PE was a T4/T8 ratio slightly higher for Tr (p less than 0.1). Our results show an increase of T4 in PE compared to blood irrespective of the etiology of PE but more pronounced for transudates. Lymphocyte subsets in PE are similar to those in B for exudates, but the same is not true for transudates that show a higher T4/T8 ratio.
Keywords: CD4-CD8 Ratio *CD4-Positive T-Lymphocytes Human Pleural Effusion, Malignant/*IMMUNOLOGY/PATHOLOGY *T-Lymphocytes, Suppressor-Effector ABSTRACT

KWDcd4-cd8ratioKWDcd4-positivet-lymphocyteshumanpleuraleffusion,malignant/KWDimmunology/pathologyKWDt-lymphocytes,suppressor-effectorabstract
920530
M9250957


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .